Difficulty: Medium
Average Score: 93%
Practice
Captopril produces a greater fall in blood pressure in
Correct answer
A
Rationale
In the context of pharmacology of CNS drugs, understanding the mechanism of action of Captopril is crucial to answering this question correctly. Captopril is an ACE inhibitor that works by blocking the conversion of angiotensin I to angiotensin II, leading to vasodilation and decreased blood pressure.
Option A is correct because diuretic-treated patients are often volume-depleted, leading to activation of the renin-angiotensin-aldosterone system. In these patients, Captopril's inhibition of angiotensin II production has a more significant impact on blood pressure reduction.
Option B is incorrect because patients with low plasma renin activity would have a reduced response to ACE inhibitors like Captopril since their renin-angiotensin system is already less active.
Option C is incorrect because sodium replete normotensive individuals do not have an overactive renin-angiotensin system that can be effectively targeted by Captopril.
Option D is incorrect because untreated CHF patients may have a compromised renin-angiotensin system due to heart failure, which can limit the efficacy of ACE inhibitors like Captopril in reducing blood pressure.
In an educational context, this question highlights the importance of considering the patient's physiological status and drug mechanisms when selecting appropriate pharmacological treatments. Understanding how different patient conditions can influence drug responses is essential for effective pharmacotherapy.
Option A is correct because diuretic-treated patients are often volume-depleted, leading to activation of the renin-angiotensin-aldosterone system. In these patients, Captopril's inhibition of angiotensin II production has a more significant impact on blood pressure reduction.
Option B is incorrect because patients with low plasma renin activity would have a reduced response to ACE inhibitors like Captopril since their renin-angiotensin system is already less active.
Option C is incorrect because sodium replete normotensive individuals do not have an overactive renin-angiotensin system that can be effectively targeted by Captopril.
Option D is incorrect because untreated CHF patients may have a compromised renin-angiotensin system due to heart failure, which can limit the efficacy of ACE inhibitors like Captopril in reducing blood pressure.
In an educational context, this question highlights the importance of considering the patient's physiological status and drug mechanisms when selecting appropriate pharmacological treatments. Understanding how different patient conditions can influence drug responses is essential for effective pharmacotherapy.